Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Profound Medical's share price for the quarter that ended in Mar. 2024 was $8.53. Profound Medical's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 24.43 Mil. Therefore, Profound Medical's market cap for the quarter that ended in Mar. 2024 was $208.38 Mil.
Profound Medical's quarterly market cap
declined
from Sep. 2023 ($217.93 Mil) to Dec. 2023 ($181.44 Mil) but then
increased
from Dec. 2023 ($181.44 Mil) to Mar. 2024 ($208.38 Mil).
Profound Medical's annual market cap
declined
from Dec. 2021 ($233.32 Mil) to Dec. 2022 ($227.38 Mil) and
declined
from Dec. 2022 ($227.38 Mil) to Dec. 2023 ($181.44 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Profound Medical's Enterprise Value for Today is $145.92 Mil.
Profound Medical Market Cap Historical Data
The historical data trend for Profound Medical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Profound Medical's Market Cap
For the Medical Devices subindustry, Profound Medical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Profound Medical's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's Market Cap distribution charts can be found below:
* The bar in red indicates where Profound Medical's Market Cap falls into.
Profound Medical Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Profound Medical's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Profound Medical (NAS:PROF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Profound Medical Market Cap Related Terms
Thank you for viewing the detailed overview of Profound Medical's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Profound Medical (Profound Medical) Business Description
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PROF has been successfully added to your 